BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20625760)

  • 1. Slowly progressive non-neoplastic autoimmune-like retinopathy.
    Ohta K; Kikuchi T; Yoshida N
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
    [No Abstract]   [Full Text] [Related]  

  • 2. Slowly progressive cancer-associated retinopathy.
    Saito W; Kase S; Ohguro H; Furudate N; Ohno S
    Arch Ophthalmol; 2007 Oct; 125(10):1431-3. PubMed ID: 17923561
    [No Abstract]   [Full Text] [Related]  

  • 3. Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy.
    Faez S; Loewenstein J; Sobrin L
    JAMA Ophthalmol; 2013 Jan; 131(1):113-5. PubMed ID: 23307224
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
    Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
    Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
    Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
    Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
    Adamus G; Ren G; Weleber RG
    BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography findings in autoimmune retinopathy.
    Abazari A; Allam SS; Adamus G; Ghazi NG
    Am J Ophthalmol; 2012 Apr; 153(4):750-6, 756.e1. PubMed ID: 22245461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated retinopathy vs recoverin-associated retinopathy.
    Keltner JL; Thirkill CE
    Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
    [No Abstract]   [Full Text] [Related]  

  • 10. Controversies of diagnosing autoimmune retinopathy.
    Heckenlively JR; Ferreyra HA; Jayasundera T
    Arch Ophthalmol; 2010 Jan; 128(1):147-8; author reply 148-9. PubMed ID: 20065241
    [No Abstract]   [Full Text] [Related]  

  • 11. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
    Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
    Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperautofluorescent ring in autoimmune retinopathy.
    Lima LH; Greenberg JP; Greenstein VC; Smith RT; Sallum JM; Thirkill C; Yannuzzi LA; Tsang SH
    Retina; 2012 Jul; 32(7):1385-94. PubMed ID: 22218149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab treatment for nonparaneoplastic autoimmune retinopathy.
    Fox A; Jeffrey B; Hasni S; Nussenblatt R; Sen HN
    Can J Ophthalmol; 2015 Dec; 50(6):e101-4. PubMed ID: 26651312
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretinal antibody- proven autoimmune retinopathy.
    Abraham S; Sudharshan S; Bhende M; Ganesh SK; Gopal S
    Indian J Ophthalmol; 2017 May; 65(5):416-420. PubMed ID: 28574003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal imaging in non-paraneoplastic autoimmune retinopathy.
    Kasongole D; Raval V; Mruthyunjaya P; Narayanan R
    Indian J Ophthalmol; 2019 Jul; 67(7):1171-1173. PubMed ID: 31238443
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune retinopathy after chronic renal allograft rejection.
    Yanagi Y; Eguchi R; Obata R; Kami J; Tamaki Y
    Arch Ophthalmol; 2006 Mar; 124(3):418-20. PubMed ID: 16534065
    [No Abstract]   [Full Text] [Related]  

  • 17. Müller cell-specific autoantibodies in a patient with progressive loss of vision.
    Peek R; Verbraak F; Coevoet HM; Kijlstra A
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1976-9. PubMed ID: 9727423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss.
    Carboni G; Forma G; Bond AD; Adamus G; Iannaccone A
    Doc Ophthalmol; 2012 Aug; 125(1):63-70. PubMed ID: 22569848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antiretinal autoantibodies in serum by Western blotting.
    Adamus G; Wilson DJ
    JAMA Ophthalmol; 2013 Oct; 131(10):1371. PubMed ID: 24114139
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoimmune retinopathy in the absence of cancer.
    Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
    Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.